Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FP.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.571EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.55 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.239EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.574EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.332EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.141EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.591EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.468EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.131 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.586EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.366EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.380EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.148EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.376EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.607EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.337EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.158EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.602EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.273EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used